Weekly updateCompaniesRecruiting servicePost a job


    Company info:

  • 51-100
  • 2015
  • New York, NY
  • 100-500M



Claim company profile

About company:

Kallyope is exploring the gut-brain axis to discover therapeutics. The gut-brain axis refers to the bi-directional communication between the organs that regulate numerous physiological processes. Many diseases including obesity and diabetes are suspected to be caused by perturbations in the gut-brain axis. By exploring the axis using a systems biology approach and combining the research output with drug discovery expertise, Kallyope is identifying small molecule therapeutics that can restore effective communication. The approach involves Kallyope’s Klarity Platform, an end-to-end process that integrates information from single-cell sequencing, optogenetics, organoids and human genetics with their gut-targeted chemistry of small molecules to build a diverse portfolio of therapies.


Director, In Vitro Pharmacology
New York City, NY|70 days ago
Director, Head of IT
New York City, NY|100+ days ago
Senior Clinical Scientist
New York City, NY|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com